1. Blanc, Valerie, Riordan, Jesse D, Soleymanjahi, Saeed, Roberts, Lewis R, Davidson, Nicholas O. . Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer. In The Journal of clinical investigation, 131, . doi:10.1172/JCI138699. https://pubmed.ncbi.nlm.nih.gov/33445170/
2. Uchiumi, Fumiaki, Katsuda, Chihiro, Akui, Motohiro, Asai, Masashi, Tanuma, Sei-Ichi. 2020. Effect of the natural compound trans‑resveratrol on human MCM4 gene transcription. In Oncology reports, 44, 283-292. doi:10.3892/or.2020.7598. https://pubmed.ncbi.nlm.nih.gov/32377740/
3. Sheng, Yue, Wei, Jiangbo, Yu, Fang, He, Chuan, Qian, Zhijian. . A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication. In Blood, 138, 2838-2852. doi:10.1182/blood.2021011707. https://pubmed.ncbi.nlm.nih.gov/34255814/
4. Wu, Xianxian, Sui, Zhilin, Zhang, Hongdian, Wang, Ying, Yu, Zhentao. 2020. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma. In Frontiers in oncology, 10, 554759. doi:10.3389/fonc.2020.554759. https://pubmed.ncbi.nlm.nih.gov/33042838/
5. Chen, Shanshan, Zhang, Yongchao, Ding, Xiaoyan, Li, Wei. 2022. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma. In Frontiers in genetics, 13, 838869. doi:10.3389/fgene.2022.838869. https://pubmed.ncbi.nlm.nih.gov/35386284/
6. Xu, Yan, Yang, Xueling, Si, Tongguo, Xing, Wenge, Guo, Zhi. 2021. MCM4 in human hepatocellular carcinoma: a potent prognostic factor associated with cell proliferation. In Bioscience trends, 15, 100-106. doi:10.5582/bst.2021.01016. https://pubmed.ncbi.nlm.nih.gov/33716256/
7. Zheng, Ruinian, Lai, Guowei, Li, Rongfa, Cai, Limin, Jia, Jun. . Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma. In Journal of gastrointestinal oncology, 12, 153-173. doi:10.21037/jgo-20-574. https://pubmed.ncbi.nlm.nih.gov/33708433/